Q Bio’s Post

It's been nearly two years since we held the last Advanced Lateral Flow Conference. At the end of 2022 the lateral flow industry was riding a wave of exuberance following the expansion driven by Covid testing requirements. But even then we saw a time of contraction and difficulty coming and some of the key topics of that conference focused on the pain that was likely to come and methods for reallocating the newly built infrastructure for other diagnostic initiatives to ease that pain. The anticipated trough came in the 2022-2023 timeframe, with industry-wide layoffs and mothballing of infrastructure. Coupled with the higher cost of investment due to macroeconomic factors and the restriction of available capital for startups and even internal programs at larger diagnostics companies, the number of new product launches remained low through 2023. As 2024 progresses, it is now anticipated that we may be at the start of the upswing, as more capital becomes available, M&A activity increases, and the number of new product development programs rises. This year's ALFC, to be held in San Diego on February 13th and 14th will discuss some of the key issues around funding, innovation and the practicalities of development and manufacturing of lateral flow products in the current and anticipated future industry environment. There will be presentations on topics linked funding, to the opportunity presented by AI in point of care diagnostics, as well as industry panels discussing topics such as integration of digital technology with at-home testing systems. Coupled with the usual networking opportunities and exposure to all of the key industry suppliers and service providers, the ALFC is a unique opportunity for developers, manufacturers and those seeking to understand the lateral flow and point of care space. There are still some attendee and sponsor spaces available. Check out https://lnkd.in/gxU9x4jX . See you in San Diego! #ALFC2024 #Diagnostics #Conference #AssayDevelopment

This #WorldTheranosticsDay, we're thrilled to announce the "Radiotheranostics: Navigating Developmental, Commercial, and Clinical Hurdles" full-day kickoff session at WMIC 2024 in Montreal! Organized by the Translation of New Therapy (TNT) Interest Group, this interactive session will lay the groundwork for understanding the current challenges faced during the discovery, development, and commercialization of new radiotheranostic agents. Join us on September 9th to enhance your understanding, forge new connections, and propel your radiotheranostics work to new heights. For more details on the kickoff, please visit: https://lnkd.in/eE6FANkP The abstract submission for #WMIC2024 closes on April 12, so submit your theranostics research and join us in Montreal! Submit an abstract here: https://lnkd.in/ebZ3Uewm #Radiotheranostics #Theranostics #PrecisionMedicine

#GDASuggestions Are you ready for this evening's webinar? It will be my pleasure to moderate Renato Cuocolo explaining the paper "METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII" published on Insights Into Imaging with several leaders on #radiomics field. Renato will discuss the development of a methodological scoring tool called METRICS for assessing the quality of radiomics research. This tool, created with input from an international panel of experts, aims to improve the standardization and evaluation of radiomics studies. Key points include the importance of standardization projects, the need for reproducibility studies, and the potential impact on clinical translation. The article highlights the strengths of METRICS compared to existing tools and emphasizes the importance of methodological transparency in radiomics research. METRICS provides a structured framework for evaluating radiomics research quality and has the potential to enhance the rigor and reproducibility of studies in this field. Obviously, I will co-moderate with Pınar Yılmaz! See you this evening at 19:00 CEST! Link to the paper: https://lnkd.in/dkRBH5Jh #radiology #eusomii #AI European Society of Radiology

Yes you can use standard NaI , introduce at 1960, detectors for theranostics but with Starguide you will do it at a other level

Learn how you can acquire data from hundreds of #Cardiomyocytes per hour in the interview from the 2023 American Physiological Society Summit last summer! Our Business Development Manager Joe discussed the MultiCell System, which provides fully automated, high-speed data acquisition from hundreds of myocytes per hour. The IonOptix MultiCell System is the first of its kind, offering high throughput and high content simultaneous quantitative calcium and kinetic analysis of contractility in cardiomyocytes. Learn more about this innovative system in the video. ⬇️ https://lnkd.in/ejH8QsG4

Here we are, back from the First Meeting on Project Progress for the ANTHEM (AdvaNced Technologies for Human-centEred Medicine) Project! Last week professor Raffaele Dellacà, PhD Chiara Veneroni, and PhD student Elena Barzanti had the opportunity to participate to this congress and two works involving members of our team were presented: - "Monitoring lung impedance for individualizing mechanical ventilation" In collaboration with Anna Lavizzari and Fabio Mosca (Fondazione IRCCS Ca' Granda Foundation), Emanuela Zannin, Camilla Rigotti and Maria Luisa Ventura (Fondazione IRCCS San Gerardo dei Tintori) and Tobias Werther (Medizinische Universität Wien). - "Preliminary studies on the management of humidity in e-nose sampling systems" In collaboration with Ana Maria Tischer, Beatrice Lotesoriere and Laura Maria Teresa Capelli (Laboratorio Olfattometrico @ PoliMI) #biomed #mechanicalventilation #techres #congress

Let's talk #Theranostics at #SNMMI24. And that conversation definitely needs to include #StarGuide digital #SPECT/CT as it was designed, built, and optimized to support the quickly-growing demand for Theranostics #medicalimaging. Make it the cornerstone of your new or growing Theranostics practice. To learn more, watch this compelling episode from our video series, Tiny signs of hope - Advancing Therasnostics, done in collaboration with #BAMFHealth called "New SPECT" for Theranostics: https://lnkd.in/dB5FB3pp #gehealthcare #nuclearmedicine #molecularimaging

🔬 Upcoming Session at #ALFC2024: Dr. Dan Siman-Tov, Senior Director of R&D at Meridian Bioscience Inc. We're looking forward to Dr. Dan Siman-Tov's insightful session at the Advanced #LateralFlow Conference. As the Senior Director of R&D in Diagnostics at Meridian Bioscience, Dr. Siman-Tov brings his extensive experience to his session titled "Lateral Flow Diagnostics: Challenges, Advantages, and Technical Guidelines." 🌟 Why This Session Is Crucial: Expert Insights: With Dr. Siman-Tov's extensive background in diagnostics, attendees will gain a comprehensive understanding of the current challenges and advantages in lateral flow technology. Practical Guidance: Learn about essential technical guidelines that are critical for developing and enhancing lateral flow diagnostic tests. Future Trends: Explore how the field is evolving and what we can expect in terms of innovation and application. 🤝 This session is perfect for professionals in R&D, quality assurance, and anyone involved in the development and application of lateral flow diagnostics. Don’t miss the opportunity to gain valuable knowledge from a leading expert in the field. 📅 Haven't registered yet? Registration ends February 9 and the hotel room block closes January 26! Register here: https://lnkd.in/emRskqjd #IVD #LFA #Diagnostics #Innovation #MeridianBioscience

If you're attending #ACMGMtg24, please don't miss this talk featuring data analytics for Twist Bioscience Exome + CNV Backbone Panel - "UNLOCKING GENETIC MYSTERIES: MASTERING EXOME ANALYSIS WITH VSCLINICAL & VS-CNV" Friday, March 15th, 11:20am, Theater 2 Presented by: Nathan Fortier, Director of Research at Golden Helix, Inc. This talk will be discussing the sensitivity rate for the detection of known CNV events at all three probe densities, the impact of best-practice quality metrics and filters on sensitivity, how VarSeq’s CNV annotation capabilities can be leveraged to identify likely pathogenic CNVs, and the interpretation of clinically relevant CNVs using VSClinical. Add to Calendar: https://shorturl.at/egBO1 https://lnkd.in/gMQ9tzQp #MedicalGeneticsAwareness

Dr. Juan F. Iglesias talks about BIOSTEMI-ES trial “the 1st head-to-head randomized trial with a superiority design under long-term follow-up that shows significant differences in clinical outcomes between 2 contemporary and widely available DES for the treatment of patients with STEMI”. Learn more about #OrsiroMission DES 👉 https://ow.ly/3JmT50RSiki #BIOTRONIK #VI #BIOSTEMI #PCI #Superiority #OrsiroMission #Whatwouldyouchoose